These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35568950)

  • 1. SynBioStrainFinder: A microbial strain database of manually curated CRISPR/Cas genetic manipulation system information for biomanufacturing.
    Cai P; Han M; Zhang R; Ding S; Zhang D; Liu D; Liu S; Hu QN
    Microb Cell Fact; 2022 May; 21(1):87. PubMed ID: 35568950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous CRISPR-Cas mediated in situ genome editing: State-of-the-art and the road ahead for engineering prokaryotes.
    Liu Z; Liu J; Yang Z; Zhu L; Zhu Z; Huang H; Jiang L
    Biotechnol Adv; 2023 Nov; 68():108241. PubMed ID: 37633620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of different types of CRISPR/Cas-based systems in bacteria.
    Liu Z; Dong H; Cui Y; Cong L; Zhang D
    Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an Endogenous CRISPR-Cas System for Genome Editing in the Human Pathogen Clostridium difficile.
    Maikova A; Kreis V; Boutserin A; Severinov K; Soutourina O
    Appl Environ Microbiol; 2019 Oct; 85(20):. PubMed ID: 31399410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CrisprGE: a central hub of CRISPR/Cas-based genome editing.
    Kaur K; Tandon H; Gupta AK; Kumar M
    Database (Oxford); 2015; 2015():bav055. PubMed ID: 26120138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thermostable CRISPR/Cas9 genome editing system and its application in construction of cell factories with thermophilic bacteria: a review].
    LE Y; He X; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2022 Apr; 38(4):1475-1489. PubMed ID: 35470620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas genome editing systems in thermophiles: Current status, associated challenges, and future perspectives.
    Le Y; Sun J
    Adv Appl Microbiol; 2022; 118():1-30. PubMed ID: 35461662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex genome editing of microorganisms using CRISPR-Cas.
    Adiego-Pérez B; Randazzo P; Daran JM; Verwaal R; Roubos JA; Daran-Lapujade P; van der Oost J
    FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31087001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
    Xu Z; Li Y; Li M; Xiang H; Yan A
    Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data Comparison and Software Design for Easy Selection and Application of CRISPR-based Genome Editing Systems in Plants.
    Wang Y; Lecourieux F; Zhang R; Dai Z; Lecourieux D; Li S; Liang Z
    Genomics Proteomics Bioinformatics; 2021 Dec; 19(6):937-948. PubMed ID: 34280549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
    Bae T; Hur JW; Kim D; Hur JK
    Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
    Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
    Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCF2Chem: A manually curated knowledge base of biosynthetic compound production.
    Cai P; Liu S; Zhang D; Hu QN
    Biotechnol Biofuels Bioprod; 2023 Nov; 16(1):167. PubMed ID: 37925500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of CRISPR/Cas gene-editing technology in yeast and fungi.
    Liao B; Chen X; Zhou X; Zhou Y; Shi Y; Ye X; Liao M; Zhou Z; Cheng L; Ren B
    Arch Microbiol; 2021 Dec; 204(1):79. PubMed ID: 34954815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versatile and multifaceted CRISPR/Cas gene editing tool for plant research.
    Pandey PK; Quilichini TD; Vaid N; Gao P; Xiang D; Datla R
    Semin Cell Dev Biol; 2019 Dec; 96():107-114. PubMed ID: 31022459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting the Type I-B CRISPR Genome Editing System in Thermoanaerobacterium aotearoense SCUT27 and Engineering the Strain for Enhanced Ethanol Production.
    Dai K; Fu H; Guo X; Qu C; Lan Y; Wang J
    Appl Environ Microbiol; 2022 Aug; 88(15):e0075122. PubMed ID: 35862665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials and promising preclinical applications of CRISPR/Cas gene editing.
    Çerçi B; Uzay IA; Kara MK; Dinçer P
    Life Sci; 2023 Jan; 312():121204. PubMed ID: 36403643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.